215 related articles for article (PubMed ID: 19225762)
1. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception.
Meyer PJ; Morgan MM; Kozell LB; Ingram SL
Psychopharmacology (Berl); 2009 Jun; 204(3):531-40. PubMed ID: 19225762
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats.
Schoo SM; Bobeck EN; Morgan MM
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):234-240. PubMed ID: 29256893
[TBL] [Abstract][Full Text] [Related]
3. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.
Morgan MM; Bobeck EN; Ingram SL
Brain Res; 2009 Oct; 1295():59-66. PubMed ID: 19664608
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of the dorsal raphe nucleus and ventrolateral periaqueductal gray to morphine antinociception and tolerance in the rat.
Campion KN; Saville KA; Morgan MM
Eur J Neurosci; 2016 Nov; 44(9):2667-2672. PubMed ID: 27564986
[TBL] [Abstract][Full Text] [Related]
5. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance.
Morgan MM; Clayton CC; Lane DA
Neuroscience; 2003; 118(1):227-32. PubMed ID: 12676152
[TBL] [Abstract][Full Text] [Related]
6. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Lane DA; Patel PA; Morgan MM
Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
[TBL] [Abstract][Full Text] [Related]
8. Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats.
Tortorici V; Nogueira L; Salas R; Vanegas H
Pain; 2003 Mar; 102(1-2):9-16. PubMed ID: 12620592
[TBL] [Abstract][Full Text] [Related]
9. Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray.
Morgan MM; Tran A; Wescom RL; Bobeck EN
Eur J Pain; 2020 Mar; 24(3):617-624. PubMed ID: 31785128
[TBL] [Abstract][Full Text] [Related]
10. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors.
Flores JA; El Banoua F; Galán-Rodríguez B; Fernandez-Espejo E
Pain; 2004 Jul; 110(1-2):205-14. PubMed ID: 15275769
[TBL] [Abstract][Full Text] [Related]
11. Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: a microdialysis study of antinociceptive circuits.
Williams FG; Mullet MA; Beitz AJ
Brain Res; 1995 Sep; 690(2):207-16. PubMed ID: 8535838
[TBL] [Abstract][Full Text] [Related]
12. The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.
Wilson-Poe AR; Pocius E; Herschbach M; Morgan MM
Pharmacol Biochem Behav; 2013 Jan; 103(3):444-9. PubMed ID: 23063785
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the periaqueductal gray in the effect of motor cortex stimulation.
Chiou RJ; Chang CW; Kuo CC
Brain Res; 2013 Mar; 1500():28-35. PubMed ID: 23337618
[TBL] [Abstract][Full Text] [Related]
14. Mu Opioid Receptor Modulation of Dopamine Neurons in the Periaqueductal Gray/Dorsal Raphe: A Role in Regulation of Pain.
Li C; Sugam JA; Lowery-Gionta EG; McElligott ZA; McCall NM; Lopez AJ; McKlveen JM; Pleil KE; Kash TL
Neuropsychopharmacology; 2016 Jul; 41(8):2122-32. PubMed ID: 26792442
[TBL] [Abstract][Full Text] [Related]
15. Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons.
Tortorici V; Morgan MM
J Neurophysiol; 2002 Oct; 88(4):1707-15. PubMed ID: 12364500
[TBL] [Abstract][Full Text] [Related]
16. Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
Wilson AR; Maher L; Morgan MM
Neuropharmacology; 2008 Dec; 55(7):1219-25. PubMed ID: 18723035
[TBL] [Abstract][Full Text] [Related]
17. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats.
Pavlovic ZW; Cooper ML; Bodnar RJ
Brain Res; 1996 Nov; 741(1-2):13-26. PubMed ID: 9001699
[TBL] [Abstract][Full Text] [Related]
18. Site-specific modulation of morphine and swim-induced antinociception following thyrotropin-releasing hormone in the rat periaqueductal gray.
Robertson JA; Bodnar RJ
Pain; 1993 Oct; 55(1):71-84. PubMed ID: 8278212
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats.
Tortorici V; Morgan MM; Vanegas H
Pain; 2001 Jan; 89(2-3):237-44. PubMed ID: 11166480
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.
Fyfe LW; Cleary DR; Macey TA; Morgan MM; Ingram SL
J Pharmacol Exp Ther; 2010 Dec; 335(3):674-80. PubMed ID: 20739455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
